1
Participants
Start Date
February 18, 2022
Primary Completion Date
May 15, 2023
Study Completion Date
February 8, 2024
TURKOVAC
Inactive COVID-19 Vaccine - TURKOVAC
CoronaVac
It has 600 subunit of SARS-CoV-2 virus antigen
Ege University Faculty of Medicine, Department of Child Health and Diseases, Izmir
Health Sciences University Adana City Training and Research Hospital, Pediatric Health and Diseases, Adana
Çukurova University Faculty of Medicine Department of Pediatric Infectious Diseases, Adana
Ankara University Faculty of Medicine Department of Pediatric Infectious Diseases, Ankara
Hacettepe University Faculty of Medicine Department of Child Health and Diseases Department of Pediatric Infectious Diseases, Ankara
Eskişehir Osmangazi University Faculty of Medicine, Department of Child Health and Diseases, Eskişehir
İstanbul University İstanbul Faculty of Medicine, Department of Pediatric Infectious Diseases, Istanbul
Marmara University Istanbul Pendik Training and Research Hospital, Pediatric Infectious Diseases Clinic, Istanbul
T.R. Ministry of Health Istanbul Provincial Health Directorate Prof. Dr. Cemil Taşçıoğlu City Hospital, Pediatric Infectious Diseases Clinic, Istanbul
University of Health Sciences İstanbul Şisli Hamidiye Etfal Training and Research Hospital, Pediatric Infectious Diseases Clinic, Istanbul
T.R. Ministry of Health İzmir Provincial Health Directorate İzmir Health Sciences University Tepecik Training and Research Hospital, Clinic of Child Health and Diseases, Izmir
University of Health Sciences İzmir Dr. Behçet Uz Child Disease and Pediatric Surgery Training and Research Hospital, Izmir
Erciyes University Faculty of Medicine Department of Pediatric Infectious Diseases, Kayseri
T.R. Ministry of Health Ankara City Hospital, Pediatric Infectious Diseases Clinic, Ankara
Health Institutes of Turkey
OTHER_GOV